These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18973505)

  • 21. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A direct comparison of intravascular ultrasound and quantitative coronary arteriography: implications for measures of atherosclerosis as clinical surrogates.
    Brown BG
    Circulation; 2007 Apr; 115(14):1824-6. PubMed ID: 17420360
    [No Abstract]   [Full Text] [Related]  

  • 23. [Protective effects of pravastatin against atherosclerosis in children with familial hypercholesterolemia].
    Riesen WF
    Rev Med Suisse; 2005 Mar; 1(9):649. PubMed ID: 15813344
    [No Abstract]   [Full Text] [Related]  

  • 24. Atherosclerosis imaging in statin intervention trials.
    Yanai H; Yoshida H; Tomono Y; Tada N
    QJM; 2007 May; 100(5):253-62. PubMed ID: 17456609
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent advances in the management of coronary artery disease: highlights from the literature.
    Augoustides JG; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):259-65. PubMed ID: 19324285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherosclerosis regression, vascular remodeling, and plaque stabilization.
    Klein LW
    J Am Coll Cardiol; 2007 Jan; 49(2):271-3. PubMed ID: 17222741
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical inquiries. Which medications benefit patients with diastolic heart failure?
    Crouse M; Flack D; Kerns JW; Martin L; Pham D; Sudireddy R; Knight K
    J Fam Pract; 2011 Feb; 60(2):101-2, 108. PubMed ID: 21301643
    [No Abstract]   [Full Text] [Related]  

  • 28. The top 50 prescription medications dispensed in pharmacies in 2008.
    Wynn RL
    Gen Dent; 2010; 58(5):360-3. PubMed ID: 20829159
    [No Abstract]   [Full Text] [Related]  

  • 29. The trouble with making combination drugs.
    Frantz S
    Nat Rev Drug Discov; 2006 Nov; 5(11):881-2. PubMed ID: 17117518
    [No Abstract]   [Full Text] [Related]  

  • 30. Subclinical atherosclerosis as a target of therapy: potential role of statins.
    Kastelein JJ; Stroes ES; de Groot E
    Am J Cardiol; 2004 Mar; 93(6):737-40. PubMed ID: 15019880
    [No Abstract]   [Full Text] [Related]  

  • 31. [Guidelines for the treatment of nephrotic syndrome].
    Japanese Society of Nephrology
    Nihon Jinzo Gakkai Shi; 2011; 53(2):78-122. PubMed ID: 21516692
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-blockers post-MI reduce progression of coronary atherosclerosis - pooled IVUS trials.
    Cardiovasc J Afr; 2007; 18(4):271-2. PubMed ID: 17940676
    [No Abstract]   [Full Text] [Related]  

  • 33. CRP and statins for primary prevention of coronary artery disease.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):97-8; quiz p following 104. PubMed ID: 19078864
    [No Abstract]   [Full Text] [Related]  

  • 34. Afibrinogenaemia: a rare cause of young myocardial infarct.
    Kumar N; Padma Kumar R; Ramesh B; Garg N
    Singapore Med J; 2008 Apr; 49(4):e104-6. PubMed ID: 18418510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
    Yakubov S
    Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vulnerable plaque: definition, detection, treatment, and future implications.
    Ozer K; Cilingiroglu M
    Curr Atheroscler Rep; 2005 Mar; 7(2):121-6. PubMed ID: 15727727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plaque stabilisation in acute coronary syndromes: clinical considerations.
    Timmis AD
    Heart; 2003 Oct; 89(10):1268-72. PubMed ID: 12975445
    [No Abstract]   [Full Text] [Related]  

  • 40. Interventional strategies in early atherosclerosis.
    Gattone M; Giannuzzi P
    Monaldi Arch Chest Dis; 2006 Mar; 66(1):54-62. PubMed ID: 17125046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.